| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GLYCOMIMETICS INC | 15,994 | 115,000 | 0.00% | ||
| 2 | ACHAOGEN INC COM | 11,700 | 153,000 | 0.00% | ||
| 3 | INFINITY PHARMACEUTICALS INC | 12,000 | 203,000 | 0.00% | ||
| 4 | QIWI PLC | 10,455 | 211,000 | 0.00% | ||
| 5 | ACHILLION PHARMACEUTICALS IN | 18,707 | 229,000 | 0.00% | ||
| 6 | AFFIMED N V COM | 36,963 | 229,000 | 0.00% | ||
| 7 | AGENUS INC | 63,341 | 251,000 | 0.00% | ||
| 8 | SUPERNUS PHARMACEUTICALS INC | 32,428 | 269,000 | 0.01% | ||
| 9 | Meta Finl Group Inc | 8,998 | 315,000 | 0.01% | ||
| 10 | Oxford Immunotec Global PLC | 26,084 | 355,000 | 0.01% | ||
| 11 | ALKERMES PLC | 6,121 | 358,000 | 0.01% | ||
| 12 | PROSPERITY BANCSHARES INC | 6,773 | 375,000 | 0.01% | ||
| 13 | PACIFIC PREMIER BANCORP | 23,019 | 399,000 | 0.01% | ||
| 14 | ProQR Therapeutics NV | 18,754 | 406,000 | 0.01% | ||
| 15 | PACIRA PHARMACEUTICALS INC | 5,087 | 451,000 | 0.01% | ||
| 16 | SVB FINANCIAL GROUP | 4,326 | 502,000 | 0.01% | ||
| 17 | VERTEX PHARMACEUTICALS INC | 4,329 | 514,000 | 0.01% | ||
| 18 | MODEL N INCORPORATED | 50,000 | 531,000 | 0.01% | ||
| 19 | AGILENT TECHNOLOGIES INC | 15,000 | 614,000 | 0.01% | ||
| 20 | ALNYLAM PHARMACEUTICALS INC | 6,370 | 618,000 | 0.01% | ||
| 21 | MCKESSON CORP | 3,000 | 623,000 | 0.01% | ||
| 22 | CELLADON CORP | 34,800 | 680,000 | 0.01% | ||
| 23 | FLUIDIGM CORP DEL COM | 20,194 | 681,000 | 0.01% | ||
| 24 | ENDOLOGIX INC | 700,000 | 686,000 | 0.01% | PRN | |
| 25 | MEDIVATION INC | 6,917 | 689,000 | 0.01% | ||
| 26 | MERIDIAN BIOSCIENCE INC | 42,800 | 704,000 | 0.01% | ||
| 27 | DEPHEID | 13,006 | 704,000 | 0.01% | ||
| 28 | BIOMARIN PHARMACEUTICAL INC | 7,875 | 712,000 | 0.01% | ||
| 29 | RELYPSA INC | 23,969 | 738,000 | 0.01% | ||
| 30 | AERIE PHARMACEUTICALS INC COM | 25,407 | 742,000 | 0.01% | ||
| 31 | ALDER BIOPHARMACEUTICALS INC | 25,596 | 745,000 | 0.01% | ||
| 32 | ACADIA PHARMACEUTICALS INC COM | 23,542 | 747,000 | 0.01% | ||
| 33 | CVS HEALTH CORP | 9,000 | 867,000 | 0.02% | ||
| 34 | CHIMERIX INC | 22,403 | 902,000 | 0.02% | ||
| 35 | SYNAGEVA BIOPHARMA CORP | 10,284 | 954,000 | 0.02% | ||
| 36 | RTI INTL METALS INC SR CV NT1.625 19 | 1,000,000 | 978,000 | 0.02% | PRN | |
| 37 | ALEXION PHARMACEUTIC | 5,390 | 997,000 | 0.02% | ||
| 38 | UNITEDHEALTH GROUP INC | 10,000 | 1,011,000 | 0.02% | ||
| 39 | TTM TECHNOLOGIES INC | 1,050,000 | 1,013,000 | 0.02% | PRN | |
| 40 | HCA HOLDINGS INC | 14,000 | 1,027,000 | 0.02% | ||
| 41 | HDFC BANK LTD | 20,380 | 1,034,000 | 0.02% | ||
| 42 | SEACOR HOLDINGS INC | 1,000,000 | 1,050,000 | 0.02% | PRN | |
| 43 | GILEAD SCIENCES INC | 11,160 | 1,052,000 | 0.02% | ||
| 44 | YOUKU TUDOU INC | 59,850 | 1,065,000 | 0.02% | ||
| 45 | BAXTER INTL INC | 15,000 | 1,099,000 | 0.02% | ||
| 46 | BECTON DICKINSON & CO | 8,000 | 1,113,000 | 0.02% | ||
| 47 | INTERCEPT PHARMACEUTICALS INCORPORATED | 7,442 | 1,161,000 | 0.02% | ||
| 48 | HEALTHCARE SVCS GRP INC | 38,372 | 1,186,000 | 0.02% | ||
| 49 | EVOLVING SYSTEMS | 146,004 | 1,365,000 | 0.03% | ||
| 50 | ARES CAP CORP | 1,450,000 | 1,497,000 | 0.03% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-000553, filed 2015.02.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
